← 產業報告目錄
New Drug Modeling Solution Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 123報告編號 APO-2cc30e4904
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global New Drug Modeling Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the New Drug Modeling Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the New Drug Modeling Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the New Drug Modeling Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of New Drug Modeling Solution include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global New Drug Modeling Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to New Drug Modeling Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
New Drug Modeling Solution Market by Company
JSR Corporation(Crown Bioscience)
Chemical Computing Group ULC
Nimbus Therapeutics
schrodinger, Inc
Genedata AG
Biognos AB
Compugen Ltd
Dassault Systemes
Acellera
lnstem(Leadscope)
New Drug Modeling Solution Segment by Type
Database
Software
Others
New Drug Modeling Solution Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Others
New Drug Modeling Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Drug Modeling Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Drug Modeling Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Drug Modeling Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of New Drug Modeling Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 New Drug Modeling Solution by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Database
2.2.3 Software
2.2.4 Others
2.3 New Drug Modeling Solution by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Drug Discovery and Development
2.3.3 Computational Physiological Medicine
2.3.4 Disease Modeling
2.3.5 Others
2.4 Assumptions and Limitations
3 New Drug Modeling Solution Breakdown Data by Type
3.1 Global New Drug Modeling Solution Historic Market Size by Type (2021-2026)
3.2 Global New Drug Modeling Solution Forecasted Market Size by Type (2027-2032)
4 New Drug Modeling Solution Breakdown Data by Application
4.1 Global New Drug Modeling Solution Historic Market Size by Application (2021-2026)
4.2 Global New Drug Modeling Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global New Drug Modeling Solution Market Perspective (2021-2032)
5.2 Global New Drug Modeling Solution Growth Trends by Region
5.2.1 Global New Drug Modeling Solution Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 New Drug Modeling Solution Historic Market Size by Region (2021-2026)
5.2.3 New Drug Modeling Solution Forecasted Market Size by Region (2027-2032)
5.3 New Drug Modeling Solution Market Dynamics
5.3.1 New Drug Modeling Solution Industry Trends
5.3.2 New Drug Modeling Solution Market Drivers
5.3.3 New Drug Modeling Solution Market Challenges
5.3.4 New Drug Modeling Solution Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top New Drug Modeling Solution Players by Revenue
6.1.1 Global Top New Drug Modeling Solution Players by Revenue (2021-2026)
6.1.2 Global New Drug Modeling Solution Revenue Market Share by Players (2021-2026)
6.2 Global New Drug Modeling Solution Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of New Drug Modeling Solution Head Office and Area Served
6.4 Global New Drug Modeling Solution Players, Product Type & Application
6.5 Global New Drug Modeling Solution Manufacturers Established Date
6.6 Global New Drug Modeling Solution Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America New Drug Modeling Solution Market Size (2021-2032)
7.2 North America New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America New Drug Modeling Solution Market Size by Country (2021-2026)
7.4 North America New Drug Modeling Solution Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe New Drug Modeling Solution Market Size (2021-2032)
8.2 Europe New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe New Drug Modeling Solution Market Size by Country (2021-2026)
8.4 Europe New Drug Modeling Solution Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific New Drug Modeling Solution Market Size (2021-2032)
9.2 Asia-Pacific New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific New Drug Modeling Solution Market Size by Country (2021-2026)
9.4 Asia-Pacific New Drug Modeling Solution Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America New Drug Modeling Solution Market Size (2021-2032)
10.2 South America New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America New Drug Modeling Solution Market Size by Country (2021-2026)
10.4 South America New Drug Modeling Solution Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa New Drug Modeling Solution Market Size (2021-2032)
11.2 Middle East & Africa New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa New Drug Modeling Solution Market Size by Country (2021-2026)
11.4 Middle East & Africa New Drug Modeling Solution Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 JSR Corporation(Crown Bioscience)
12.1.1 JSR Corporation(Crown Bioscience) Company Information
12.1.2 JSR Corporation(Crown Bioscience) Business Overview
12.1.3 JSR Corporation(Crown Bioscience) Revenue in New Drug Modeling Solution Business (2021-2026)
12.1.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Portfolio
12.1.5 JSR Corporation(Crown Bioscience) Recent Developments
12.2 Chemical Computing Group ULC
12.2.1 Chemical Computing Group ULC Company Information
12.2.2 Chemical Computing Group ULC Business Overview
12.2.3 Chemical Computing Group ULC Revenue in New Drug Modeling Solution Business (2021-2026)
12.2.4 Chemical Computing Group ULC New Drug Modeling Solution Product Portfolio
12.2.5 Chemical Computing Group ULC Recent Developments
12.3 Nimbus Therapeutics
12.3.1 Nimbus Therapeutics Company Information
12.3.2 Nimbus Therapeutics Business Overview
12.3.3 Nimbus Therapeutics Revenue in New Drug Modeling Solution Business (2021-2026)
12.3.4 Nimbus Therapeutics New Drug Modeling Solution Product Portfolio
12.3.5 Nimbus Therapeutics Recent Developments
12.4 schrodinger, Inc
12.4.1 schrodinger, Inc Company Information
12.4.2 schrodinger, Inc Business Overview
12.4.3 schrodinger, Inc Revenue in New Drug Modeling Solution Business (2021-2026)
12.4.4 schrodinger, Inc New Drug Modeling Solution Product Portfolio
12.4.5 schrodinger, Inc Recent Developments
12.5 Genedata AG
12.5.1 Genedata AG Company Information
12.5.2 Genedata AG Business Overview
12.5.3 Genedata AG Revenue in New Drug Modeling Solution Business (2021-2026)
12.5.4 Genedata AG New Drug Modeling Solution Product Portfolio
12.5.5 Genedata AG Recent Developments
12.6 Biognos AB
12.6.1 Biognos AB Company Information
12.6.2 Biognos AB Business Overview
12.6.3 Biognos AB Revenue in New Drug Modeling Solution Business (2021-2026)
12.6.4 Biognos AB New Drug Modeling Solution Product Portfolio
12.6.5 Biognos AB Recent Developments
12.7 Compugen Ltd
12.7.1 Compugen Ltd Company Information
12.7.2 Compugen Ltd Business Overview
12.7.3 Compugen Ltd Revenue in New Drug Modeling Solution Business (2021-2026)
12.7.4 Compugen Ltd New Drug Modeling Solution Product Portfolio
12.7.5 Compugen Ltd Recent Developments
12.8 Dassault Systemes
12.8.1 Dassault Systemes Company Information
12.8.2 Dassault Systemes Business Overview
12.8.3 Dassault Systemes Revenue in New Drug Modeling Solution Business (2021-2026)
12.8.4 Dassault Systemes New Drug Modeling Solution Product Portfolio
12.8.5 Dassault Systemes Recent Developments
12.9 Acellera
12.9.1 Acellera Company Information
12.9.2 Acellera Business Overview
12.9.3 Acellera Revenue in New Drug Modeling Solution Business (2021-2026)
12.9.4 Acellera New Drug Modeling Solution Product Portfolio
12.9.5 Acellera Recent Developments
12.10 lnstem(Leadscope)
12.10.1 lnstem(Leadscope) Company Information
12.10.2 lnstem(Leadscope) Business Overview
12.10.3 lnstem(Leadscope) Revenue in New Drug Modeling Solution Business (2021-2026)
12.10.4 lnstem(Leadscope) New Drug Modeling Solution Product Portfolio
12.10.5 lnstem(Leadscope) Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global New Drug Modeling Solution Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global New Drug Modeling Solution Revenue Market Share by Type (2021-2026)
Table 7. Global New Drug Modeling Solution Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global New Drug Modeling Solution Revenue Market Share by Type (2027-2032)
Table 9. Global New Drug Modeling Solution Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global New Drug Modeling Solution Revenue Market Share by Application (2021-2026)
Table 11. Global New Drug Modeling Solution Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global New Drug Modeling Solution Revenue Market Share by Application (2027-2032)
Table 13. Global New Drug Modeling Solution Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global New Drug Modeling Solution Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global New Drug Modeling Solution Market Share by Region (2021-2026)
Table 16. Global New Drug Modeling Solution Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global New Drug Modeling Solution Market Share by Region (2027-2032)
Table 18. New Drug Modeling Solution Industry Trends
Table 19. New Drug Modeling Solution Industry Drivers
Table 20. New Drug Modeling Solution Industry Opportunities and Challenges
Table 21. New Drug Modeling Solution Market Restraints
Table 22. Global Top New Drug Modeling Solution Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global New Drug Modeling Solution Revenue Market Share by Players (2021-2026)
Table 24. Global New Drug Modeling Solution Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of New Drug Modeling Solution, Headquarters and Area Served
Table 26. Global New Drug Modeling Solution Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global New Drug Modeling Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America New Drug Modeling Solution Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America New Drug Modeling Solution Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe New Drug Modeling Solution Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe New Drug Modeling Solution Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific New Drug Modeling Solution Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific New Drug Modeling Solution Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America New Drug Modeling Solution Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America New Drug Modeling Solution Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa New Drug Modeling Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa New Drug Modeling Solution Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa New Drug Modeling Solution Market Size by Country (2027-2032) & (US$ Million)
Table 45. JSR Corporation(Crown Bioscience) Company Information
Table 46. JSR Corporation(Crown Bioscience) Business Overview
Table 47. JSR Corporation(Crown Bioscience) Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 48. JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Portfolio
Table 49. JSR Corporation(Crown Bioscience) Recent Developments
Table 50. Chemical Computing Group ULC Company Information
Table 51. Chemical Computing Group ULC Business Overview
Table 52. Chemical Computing Group ULC Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 53. Chemical Computing Group ULC New Drug Modeling Solution Product Portfolio
Table 54. Chemical Computing Group ULC Recent Developments
Table 55. Nimbus Therapeutics Company Information
Table 56. Nimbus Therapeutics Business Overview
Table 57. Nimbus Therapeutics Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 58. Nimbus Therapeutics New Drug Modeling Solution Product Portfolio
Table 59. Nimbus Therapeutics Recent Developments
Table 60. schrodinger, Inc Company Information
Table 61. schrodinger, Inc Business Overview
Table 62. schrodinger, Inc Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 63. schrodinger, Inc New Drug Modeling Solution Product Portfolio
Table 64. schrodinger, Inc Recent Developments
Table 65. Genedata AG Company Information
Table 66. Genedata AG Business Overview
Table 67. Genedata AG Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 68. Genedata AG New Drug Modeling Solution Product Portfolio
Table 69. Genedata AG Recent Developments
Table 70. Biognos AB Company Information
Table 71. Biognos AB Business Overview
Table 72. Biognos AB Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 73. Biognos AB New Drug Modeling Solution Product Portfolio
Table 74. Biognos AB Recent Developments
Table 75. Compugen Ltd Company Information
Table 76. Compugen Ltd Business Overview
Table 77. Compugen Ltd Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 78. Compugen Ltd New Drug Modeling Solution Product Portfolio
Table 79. Compugen Ltd Recent Developments
Table 80. Dassault Systemes Company Information
Table 81. Dassault Systemes Business Overview
Table 82. Dassault Systemes Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 83. Dassault Systemes New Drug Modeling Solution Product Portfolio
Table 84. Dassault Systemes Recent Developments
Table 85. Acellera Company Information
Table 86. Acellera Business Overview
Table 87. Acellera Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 88. Acellera New Drug Modeling Solution Product Portfolio
Table 89. Acellera Recent Developments
Table 90. lnstem(Leadscope) Company Information
Table 91. lnstem(Leadscope) Business Overview
Table 92. lnstem(Leadscope) Revenue in New Drug Modeling Solution Business (2021-2026) & (US$ Million)
Table 93. lnstem(Leadscope) New Drug Modeling Solution Product Portfolio
Table 94. lnstem(Leadscope) Recent Developments
Table 95. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. New Drug Modeling Solution Product Image
Figure 5. Global New Drug Modeling Solution Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global New Drug Modeling Solution Market Share by Type: 2025 VS 2032
Figure 7. Database Product
Figure 8. Software Product
Figure 9. Others Product
Figure 10. Global New Drug Modeling Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global New Drug Modeling Solution Market Share by Application: 2025 VS 2032
Figure 12. Drug Discovery and Development Product
Figure 13. Computational Physiological Medicine Product
Figure 14. Disease Modeling Product
Figure 15. Others Product
Figure 16. Global New Drug Modeling Solution Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global New Drug Modeling Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global New Drug Modeling Solution Market Share by Region: 2025 VS 2032
Figure 19. Global New Drug Modeling Solution Market Share by Players in 2025
Figure 20. Global New Drug Modeling Solution Manufacturers Established Date
Figure 21. Global Top 5 and 10 New Drug Modeling Solution Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 25. United States New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 28. Europe New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 30. Germany New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 40. China New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 45. Australia New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America New Drug Modeling Solution Market Share by Country (2021-2032)
Figure 50. Brazil New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru New Drug Modeling Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. JSR Corporation(Crown Bioscience) Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 56. Chemical Computing Group ULC Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 57. Nimbus Therapeutics Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 58. schrodinger, Inc Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 59. Genedata AG Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 60. Biognos AB Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 61. Compugen Ltd Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 62. Dassault Systemes Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 63. Acellera Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
Figure 64. lnstem(Leadscope) Revenue Growth Rate in New Drug Modeling Solution Business (2021-2026)
提及公司
JSR Corporation(Crown Bioscience)Chemical Computing Group ULCNimbus Therapeuticsschrodinger, IncGenedata AGBiognos ABCompugen LtdDassault SystemesAcelleralnstem(Leadscope)
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們